GRANULES INDIA LTD.-$ - 532482 - Closure of Trading Window
Intimation of Trading Window Closure28-06-2023
GRANULES INDIA LTD.-$ - 532482 - Closure of Trading Window
Intimation of Trading Window ClosureGRANULES INDIA LTD.-$ - 532482 - Granules India'S Jeedimetla Facility Completed The US FDA Inspection
Granules India's Jeedimetla facility completed the US FDA inspectionBuy Granules India; target of Rs 360: ICICI Direct
ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 360 in its research report dated June 19, 2023.GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited Receives ANDA Approval for Levetiracetam TabletsBuy Granules India; target of Rs 342: Geojit
Geojit is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 342 in its research report dated June 13, 2023.GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited Received ANDA Approval for Metoprolol Succinate ER TabletsGRANULES INDIA LTD.-$ - 532482 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report under Regulation 24A for the FY 2022-23GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst/ Investor MeetGRANULES INDIA LTD.-$ - 532482 - Transcript Of The Earnings Conference Call For Q4 And Financial Year Ended On March 31, 2023
Transcript of the Earnings Conference call for Q4 and financial year ended on March 31, 2023